Hypersensitivity related to abacavir in two members of a family [1]

Annals of Pharmacotherapy

Volumn 35, Issue 10, 2001, Pages 1291-1292

  Peyriere H ^a   Nicolas, J ^a   Siffert, M ^a   Demoly, P ^a   Hillaire Buys, D ^a   Reynes, J ^a  

^a Hopital Saint Charles   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; C REACTIVE PROTEIN; CD23 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; CYTOCHROME P450; EFAVIRENZ; HLA DR ANTIGEN; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LEUKOCYTE COUNT; MALAISE; MALE; NAUSEA; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; VIRUS TRANSMISSION; VOMITING;

EID: 0034798191     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A022     Document Type: Letter

References (7)

1. Abacavir safety and tolerability: Experience from over 25,000 adults and children
2. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction
3. Anaphylaxis after rechallenge with abacavir
4. A method for estimating the probability of adverse drug reactions
5. Management protocol for abacavir-related hypersensitivity reaction
6. Allergic reactions to drugs and biologic agents
7. Immunohistologic characterization of skin rash observed in patients on abacavir who experience a hypersensitivity reaction